George Migausky
Direktor/Vorstandsmitglied bei IMMUNOVANT, INC.
Vermögen: 4 Mio $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von George Migausky
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Boston College
124
| College/University | Other Consumer Services | 124 |
| Public Company | Biotechnology | 28 | |
25
| Subsidiary | Pharmaceuticals: Major | 25 |
Massachusetts Eye & Ear Infirmary, Inc.
 Massachusetts Eye & Ear Infirmary, Inc. Medical/Nursing ServicesHealth Services Massachusetts Eye & Ear Infirmary operates as hospital that provides patient care for disorders of the eye, ear, nose, throat, head and neck. It offers ophthalmology and otolaryngology research services and is a teaching partner of Harvard Medical School. The firm’s programs and services include anesthesiology, ophthalmology, otolaryngology, radiology, Coolidge Clinic laboratory and libraries. The company was founded in 1824 and is headquartered in Boston, MA.
24
| Non-Profit Organization | Medical/Nursing Services | 24 |
| Public Company | Pharmaceuticals: Major | 22 | |
| Subsidiary | Biotechnology | 16 | |
BioVeris Corp.
 BioVeris Corp. BiotechnologyHealth Technology BioVeris Corp. developed and manufactured diagnostic products. It operates as a global health care and biosecurity company that developing proprietary technologies in diagnostics and vaccinology. The firm specializes in electrochemiluminescence and immunochemistry. The company was founded in 2003 and is headquartered in Gaithersburg, MD.
11
| Extinct | Biotechnology | 11 |
| Public Company | Pharmaceuticals: Major | 10 | |
| Public Company | Pharmaceuticals: Major | 7 | |
IGEN International, Inc.
 IGEN International, Inc. Medical SpecialtiesHealth Technology IGEN International, Inc. develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing. The company was founded in 1982 and is headquartered in Gaithersburg, MD.
6
| Extinct | Medical Specialties | 6 |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million.
5
| Subsidiary | Biotechnology | 5 |
Wellstat Management Co. LLC
 Wellstat Management Co. LLC Miscellaneous Commercial ServicesCommercial Services Wellstat Management Co. LLC provides management, legal, financial, human resources, information technology, business development, transactional, investment, licensing, and other services to the Wellstat group of companies. The company was founded by Samuel J. Wohlstadter in 2007 and is headquartered in Rockville, MD.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von George Migausky
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Founder Director/Board Member Director of Finance/CFO Comptroller/Controller/Auditor | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal President | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Corporate Officer/Principal Graduate Degree Doctorate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Chief Tech/Sci/R&D Officer Chairman Chief Operating Officer | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
FOXKISER LLP
 FOXKISER LLP Miscellaneous Commercial ServicesCommercial Services FOXKISER LLP engages in the provision of strategic advice and counseling services to pharmaceutical and biotechnology companies. Its project works fall into three general categories: advisory services; long-term partnerships; and new company formation. The company was founded by John Daniel Kiser and Allan M. Fox in September 1986 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Founder Corporate Officer/Principal Corporate Officer/Principal | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Private Equity Analyst Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Chicago | College/University | Undergraduate Degree Masters Business Admin Doctorate Degree | |
Meso Scale Diagnostics LLC
 Meso Scale Diagnostics LLC Medical SpecialtiesHealth Technology Meso Scale Diagnostics LLC develops and markets solutions for multiplex biological assays. Its products include angiogenesis and vascular, bone metabolism, cytokine and chemokine, inflammation, intracellular signaling, neurodegeneration, toxicology, and immuno assay kits. The firms services include assay development, custom conjugation, prototype printing, instrument services and warranties. The company was founded in 1995 and is headquartered in Rockville, MD. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Masters Business Admin Graduate Degree Graduate Degree | |
| CELGENE | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Robert H. Smith School of Business | College/University | Graduate Degree Masters Business Admin | |
| University of Vermont | College/University | Doctorate Degree Corporate Officer/Principal | |
| EDITAS MEDICINE, INC. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| Suffolk University Law School | College/University | Graduate Degree Graduate Degree | |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Director/Board Member General Counsel | |
| IMMUNOMEDICS, INC. | Biotechnology | Investor Relations Contact Chief Tech/Sci/R&D Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Sales & Marketing | |
Flamingo Therapeutics BV
 Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
| MINERVA NEUROSCIENCES, INC. | Pharmaceuticals: Major | Founder General Counsel | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree | |
| REVO BIOLOGICS INC | Biotechnology | Director/Board Member Director/Board Member | |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Public Communications Contact Corporate Officer/Principal | |
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Chairman Director/Board Member | |
| REGENETP, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Chairman Director/Board Member | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel Compliance Officer | |
| DISC MEDICINE, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer |
Statistik
International
| Vereinigte Staaten | 47 |
| Vereinigtes Königreich | 2 |
| Belgien | 2 |
| Frankreich | 2 |
| Niederlande | 2 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 15 |
| Commercial Services | 5 |
| Finance | 2 |
| Government | 2 |
Operativ
| Director/Board Member | 482 |
| Corporate Officer/Principal | 213 |
| Independent Dir/Board Member | 164 |
| Chairman | 93 |
| Chief Executive Officer | 74 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Annalisa Jenkins | 51 |
| Argeris Karabelas | 42 |
| Frank Torti | 35 |
| Georges Gemayel | 33 |
| Alan Colowick | 30 |
| Arlene Morris | 28 |
| Mary Gray | 27 |
| Robert Knapp | 27 |
| Marc Kozin | 24 |
| Shawn Tomasello | 22 |
| Thomas Lenox Kempner | 21 |
| Atul Pande | 20 |
| James M. Garvey | 20 |
| Minnie Baylor-Henry | 20 |
| Susan B. Bayh | 20 |
- Börse
- Insiders
- George Migausky
- Unternehmensverbindungen
